Clinical Trial Update: Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes [NA]

View source ↗

Summary

A clinical trial evaluating repaglinide for adolescents with cystic fibrosis-related diabetes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis-related Diabetes
• Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Diabetes | NA | Status: WITHDRAWN